Comparative glycomic profiling of isotopically permethylated N-glycans by liquid chromatography/electrospray ionization mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 27, Issue 8, 2013, Pages 865-877

  Hu, Yunli ^a   Desantos Garcia, Janie L ^a   Mechref, Yehia ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; IONIZATION OF LIQUIDS; ISOTOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POLYSACCHARIDES;

BIO-MARKER DISCOVERY; BIOLOGICAL SAMPLES; BLOOD SERUM; DISEASE BIOMARKER; GLYCOMICS; IODOMETHANE; LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-MASS SPECTROMETRIES; MASS SPECTROMETRY ANALYSIS; N-GLYCAN; SERUM SAMPLES;

GLYCOPROTEINS;

EID: 84875204783     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.6512     Document Type: Article

References (42)

1. R. Apweiler, H. Hermjakob, N. Sharon,. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta: Gen. Subjects 1999, 1473, 4.
2. G. W. Hart, R. J. Copeland,. Glycomics hits the big time. Cell 2010, 143, 672.
3. A. Varki, R. D. Cummings, J. D. Esko, H. H. Freeze, P. Stanley, C. R. Bertozzi, G. W. Hart, M. E. Etzler,. Essentials of Glycobiology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2009.
4. D. H. Dube, C.R. Bertozzi,. Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat. Rev. Drug. Discov. 2005, 4, 477.
5. P. M. Rudd, T. Elliott, P. Cresswell, I. A. Wilson, R. A. Dwek,. Glycosylation and the immune system. Science 2001, 291, 2370.
6. J. W. Dennis, M. Granovsky, C. E. Warren,. Protein glycosylation in development and disease. Bioassays 1999, 21, 412.
7. J. W. Dennis, S. Laferte, C. Waghorne, M. L. Breitman, R. S. Kerbel,. b1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987, 236, 582.
8. S. Hakomori,. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)-lipid metabolism. Cancer Res. 1996, 56, 5309.
9. S. Hakomori,. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc. Nat. Acad. Sci. USA 2002, 16, 10232.
10. M. V. Dwek, H. A. Lacey, A. J. C. Leathem,. Breast cancer progression is associated with a reduction in the diversity of sialylated and neutral oligosaccharides. Clin. Chim. Acta 1998, 271, 191.
11. R. A. Dwek,. Glycobiology: Toward understanding the function of sugars. Chem. Rev. 1996, 96, 683.
12. W. R. Alley, M. V. Novotny,. Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins. J. Proteome Res. 2010, 9, 3062.
13. H. J. An, S. R. Kronewitter, M. L. A. de Leoz, C. B. Lebrilla,. Glycomics and disease markers. Curr. Opin. Chem. Biol. 2009, 13, 601.
14. H. J. An, S. Miyamoto, K. S. Lancaster, C. Kirmiz, B. Li, K. S. Lam, G. S. Leiserowitz, C. B. Lebrilla,. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J. Proteome Res. 2006, 5, 1626.
15. I. Brockhausen, J. M. Yang, J. Burchell, C. Whitehouse, J. Taylor-Papadimitriou,. Mechanism underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur. J. Biochem. 1995, 233, 607.
16. B. Davidson, W. H. Gotlieb, G. Ben-Baruch, J. Kopolovic, I. Goldberg, J. M. Nesland, A. Berner, A. Bjamer, M. Bryne,. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study. Gynecol. Oncol. 2000, 77, 35.
17. M. L. A. de Leoz, H. J. An, S. Kronewitter, J. Kim, S. Beecroft, R. Vinall, S. Miyamoto, R. De Vere White, K. S. Lam, C. B. Lebrilla,. Glycomic approach for potential biomarkers on prostate cancer: Profiling of N-linked glycans in human sera and pRNS cell lines. Disease Markers 2008, 25, 243.
18. J. A. Goetz, Y. Mechref, P. Kang, M.-H. Jeng, M. V. Novotny,. Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconjugate J. 2009, 26, 117.
19. R. Goldman, H. W. Ressom, R. S. Varghese, L. Goldman, G. Bascug, C. A. Loffredo, M. Abdel-Hamid, I. Gouda, S. Ezzat, Z. Kyselova, Y. Mechref, M. V. Novotny,. Detection of hepatocellular carcinoma using glycomic analysis. Clin. Cancer Res. 2009, 15, 1808.
20. D. Isailovic, R. T. Kurulugama, M. D. Plasencia, S. T. Stokes, Z. Kyselova, R. Goldman, Y. Mechref, M. V. Novotny, D. E. Clemmer,. Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS. J. Proteome Res. 2008, 7, 1100.
21. Z. Kyselova, Y. Mechref, M. M. Al Bataineh, L. E. Dobrolecki, R. J. Hickey, J. Vinson, C. J. Sweeney, M. V. Novotny,. Alterations in the serum glycome due to metastatic prostate cancer. J. Proteome Res. 2007, 6, 1822.
22. Z. Kyselova, Y. Mechref, P. Kang, J. A. Goetz, L. E. Dobrolecki, G. Sledge, L. Schnaper, R. J. Hickey, L. H. Malkas, M. V. Novotny,. Breast cancer diagnosis/prognosis through quantitative measurements of serum glycan profiles. Clin. Chem. 2008, 54, 1166.
23. Y. Mechref, A. Hussein, S. Bekesova, V. Pungpapong, M. Zhang, L. E. Dobrolecki, R. J. Hickey, Z. T. Hammoud, M. V. Novotny,. Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J. Proteome Res. 2009, 8, 2656.
24. J. Zhao, T. H. Patwa, W. Qiu, K. Shedden, R. Hinderer, D. E. Misek, M. A. Anderson, D. M. Simeone, D. M. Lubman,. Glycoprotein microarrays with multi-lectin detection: Unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. J. Proteome Res. 2007, 6, 1864.
25. Y. Mechref, Y. Hu, A. Garcia, A. Hussien,. Disease biomarkers through mass spectrometry based glycomics. Electrophoresis 2012, 33, 1755.
26. R. Orlando, J.-M. Lim, J. A. Atwood, P. M. Angel, M. Fang, K. Aoki, G. Alvarez-Manilla, K. W. Moremen, W. S. York, M. Tiemeyer, M. Pierce, S. Dalton, L. Wells,. IDAWG: Metabolic incorporation of stable isotope labels for quantitative glycomics of cultured cells. J. Proteome Res. 2009, 8, 3816.
27. M. J. Bowman, J. Zaia,. Tags for the stable isotopic labeling of carbohydrates and quantitative analysis by mass spectrometry. Anal. Chem. 2007, 79, 5777.
28. J. M. Prien, B. D. Prater, Q. Qin, S. L. Cockrill,. Mass spectrometric-based stable isotopic 2-aminobenzoic acid glycan mapping for rapid glycan screening of biotherapeutics. Anal. Chem. 2010, 82, 1498.
29. S. H. Walker, J. Budhathoki-Uprety, B. M. Novak, D. C. Muddiman,. Glycoprotein analysis using mass spectrometry: unraveling the layers of complexity. Anal. Chem. 2011, 83, 6738.
30. B. Xia, C. L. Feasley, G. P. Sachdev, D. F. Smith, R. D. Cummings,. Glycan reductive isotope labeling for quantitative glycomics. 2009, 387, 162.
31. R. Orlando, J. Lim, J. A. Atwood, P.M. Angel, M. Fang, A. Kazuhiro, G. Alvarez-Manilla, K. W. Moreman, W. S. York, M. Tiemeyer, M. Pierce, S. Dalton, L. Wells,. IDAWG: Metabolic incorporation of stable isotope labels for quantitative glycomics of cultured cells. J. Proteome Res. 2009, 8, 3816.
32. P. Kang, Y. Mechref, Z. Kyselova, J. A. Goetz, M. V. Novotny,. Comparative glycomic mapping through quantitative permethylation and stable-isotope labeling. Anal. Chem. 2007, 79, 6064.
33. J. Yuan, N. Hashii, N. Kawasaki, S. Itoh, T. Kawanishi, T. Hayakawa,. Isotope tag method for quantitative analysis of carbohydrates by liquid chromatography-mass spectrometry. J. Chromatogr. A 2005, 1067, 145.
34. A. M. Hitchcock, C. E. Costello, J. Zaia,. Glycoform quantification of chondroitin/dermatan sulfate using a liquid chromatography-tandem mass spectrometry platform. Biochemistry 2006, 45, 2350.
35. J. L. Desantos-Garcia, S. I. Khalil, A. Hussein, Y. Hu, Y. Mechref,. Enhanced sensitivity of LC-MS analysis of permethylated N-glycans through online purification. Electrophoresis 2011, 32, 3516.
36. Y. Hu, Y. Mechref,. Comparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serum. Electrophoresis 2012, 33, 1768.
37. P. Kang, Y. Mechref, M. V. Novotny,. High-throughput solid-phase permethylation of glycans prior to mass spectrometry. Rapid Commun. Mass Spectrom. 2008, 22, 721.
38. Y. Mechref, P. Kang, M. V. Novotny, Solid-phase permethylation for glycomic analysis. Methods Mol. Biol. 2009, 534, 53.
39. D. Isailovic, R. T. Kurulugama, M. D. Plasencia, S. T. Stokes, Z. Kyselova, R. Goldman, Y. Mechref, M. V. Novotny, D. E. Clemmer,. Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS. J. Proteome Res. 2008, 7, 1109.
40. Z. Kyselova, Y. Mechref, M. M. Al Bataineh, L. E. Dobrolecki, R. J. Hickey, J. Vinson, C. J. Sweeney, M. V. Novotny,. Alterations in the serum glycome due to metastatic prostate cancer. J. Proteome Res. 2007, 6, 1822.
41. Y. Mechref, A. Hussein, S. Bekesova, V. Pungpapong, M. Zhang, L. E. Dobrolecki, R. J. Hickey, Z. T. Hammoud, M. V. Novotny,. Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J. Proteome Res. 2009, 8, 2656.
42. P. Kang, Y. Mechref, I. Klouckova, M. V. Novotny,. Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun. Mass Spectrom. 2005, 19, 3421.